We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Form (P7) to submit a sample to UKHSA to test for the monkeypox virus (MPXV).
Pre-MVA vaccination against monkeypox checklist and consent form.
Recommendations for the use of pre- and post-exposure vaccination during an mpox incident.
The UK strategy for mpox control 2022 to 2023 outlines the UK’s 4 nation plan to continue reducing mpox transmission over the next 12 months.
Interim guidance to support NHS Trusts in managing the de-isolation and discharge of mpox-infected patients.
UKHSA has undertaken assessments of inactivation methods against monkeypox virus with further evaluations ongoing.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.